Data / Drug companies / Laboratorium Ofichem BV
Laboratorium Ofichem BV: 22 products in the FDA NDC directory, labeler code 62675
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Laboratorium Ofichem BV (labeler code 62675) lists 22 products in the FDA National Drug Code Directory. By type: 22 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on August 20, 2025.
The request: Watch Laboratorium Ofichem BV (FDA labeler code 62675): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 62675
- Products in commercial distribution
- 22
- Packages
- 22
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- December 11, 2017
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 22 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 22 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 22 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Guanabenz acetate | 62675-1903 | Powder | Bulk ingredients | August 20, 2025 |
| Edetate disodium | 62675-2751 | Powder | Bulk ingredients | April 24, 2023 |
| S,s-reboxetine succinate | 62675-2507 | Powder | Bulk ingredients | January 9, 2023 |
| Reboxetine mesylate | 62675-2286 | Powder | Bulk ingredients | January 9, 2023 |
| Edetate calcium disodium | 62675-2350 | Powder | Bulk ingredients | October 11, 2021 |
| Methenamine mandelate | 62675-1072 | Powder | Bulk ingredients | November 22, 2020 |
| R-buproprion hydrochloride | 62675-1524 | Powder | Bulk ingredients | December 2, 2019 |
| S-buproprion hydrochloride | 62675-1456 | Powder | Bulk ingredients | December 2, 2019 |
| Zinc monoethylfumarate micronized | 62675-1715 | Powder | Bulk ingredients | July 2, 2018 |
| Magnesium monoethylfumarate micronized | 62675-1714 | Powder | Bulk ingredients | July 2, 2018 |
| Calcium monoethylfumarate micronized | 62675-1713 | Powder | Bulk ingredients | July 2, 2018 |
| Zinc acetate dihydrate milled | 62675-1444 | Powder | Bulk ingredients | July 2, 2018 |
| Dimethylfumarate micronized | 62675-1383 | Powder | Bulk ingredients | July 2, 2018 |
| Palmitoylethanolamide | 62675-1309 | Powder | Bulk ingredients | July 2, 2018 |
| Potassium bromide | 62675-1225 | Powder | Bulk ingredients | July 2, 2018 |
| Pamidronate disodium pentahydrate | 62675-0718 | Powder | Bulk ingredients | July 2, 2018 |
| Zinc monoethylfumarate | 62675-0528 | Powder | Bulk ingredients | July 2, 2018 |
| Magnesium monoethylfumarate | 62675-0527 | Powder | Bulk ingredients | July 2, 2018 |
| Calcium monoethylfumarate | 62675-0525 | Powder | Bulk ingredients | July 2, 2018 |
| Sulfadiazine sodium | 62675-0320 | Powder | Bulk ingredients | July 2, 2018 |
| Dimethyl fumarate | 62675-0393 | Powder | Bulk ingredients | January 1, 2018 |
| Histamine dihydrochloride | 62675-0969 | Powder | Bulk ingredients | December 11, 2017 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.